Just The Tonix: New York Biotech Has Breakthrough Drug For PTSD
Tonix Pharmaceuticals has won a breakthrough therapy designation this month for its post-traumatic stress disorder drug – the most advanced product in development specifically for the condition and potentially the first ever to market targeting PTSD as its lead indication.
You may also be interested in...
A number of pivotal studies are expected to report top-line data in the third quarter. Here, with the help of Informa Pharma's Biomedtracker, we take a look at eight of those likely to be major catalysts for their sponsors.
The latest drug development news and highlights from our FDA Performance Tracker.
UK special envoy on antimicrobial resistance Professor Dame Sally Davies, who is also the former chief medical officer for England, talks to In Vivo about the challenges of 2020, the importance of a strong working relationship between the public and private sectors, and reaching a turning point on AMR.